Matrix metalloproteinases and failed fracture healing.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 16199217)

Published in Bone on September 30, 2005

Authors

Philipp Henle1, Gerald Zimmermann, Stefan Weiss

Author Affiliations

1: Stiftung Orthopädische Universitätsklinik Heidelberg, Schlierbacher Landstrasse 200 A, 69118 Heidelberg, Germany.

Articles citing this

Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration. PLoS One (2007) 1.29

Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics. Acta Orthop (2009) 1.16

Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing. Injury (2011) 1.09

Altered relative expression of BMPs and BMP inhibitors in cartilaginous areas of human fractures progressing towards nonunion. J Orthop Res (2009) 0.97

Growth factor delivery: how surface interactions modulate release in vitro and in vivo. Adv Drug Deliv Rev (2012) 0.93

Detection of bone and cartilage-related proteins in plasma of patients with a bone fracture using liquid chromatography-mass spectrometry. Int Orthop (2007) 0.89

Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation. J Control Release (2014) 0.89

Special Review: Accelerating fracture repair in humans: a reading of old experiments and recent clinical trials. Bonekey Rep (2013) 0.84

Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing. Crit Rev Eukaryot Gene Expr (2010) 0.82

Biological and molecular profile of fracture non-union tissue: current insights. J Cell Mol Med (2015) 0.81

Elevated plasma levels of TIMP-1 in patients with rotator cuff tear. Acta Orthop (2012) 0.81

Upregulation of MMP-13 and TIMP-1 expression in response to mechanical strain in MC3T3-E1 osteoblastic cells. BMC Res Notes (2010) 0.80

Urine matrix metalloproteinases (MMPs) as biomarkers for the progression of fracture healing. Injury (2012) 0.79

Serum metalloproteinases 2 and 9 as predictors of gait status, pressure ulcer and mortality after hip fracture. PLoS One (2013) 0.78

Mineralization content alters osteogenic responses of bone marrow stromal cells on hydroxyapatite/polycaprolactone composite nanofiber scaffolds. J Funct Biomater (2012) 0.75

MMP-8 Is Critical for Dexamethasone Therapy in Alkali-Burned Corneas Under Dry Eye Conditions. J Cell Physiol (2016) 0.75

Articles by these authors

Cigarette smoking influences the clinical and occupational outcome of patients with tibial shaft fractures. Injury (2011) 2.34

Toxoplasma gondii myosin A and its light chain: a fast, single-headed, plus-end-directed motor. EMBO J (2002) 2.22

The psychosocial burden of psoriasis. Am J Clin Dermatol (2005) 1.81

What kinesin does at roadblocks: the coordination mechanism for molecular walking. EMBO J (2003) 1.41

Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem (2002) 1.41

The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep (2003) 1.23

The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J Infect Dis (2006) 1.20

Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials (2005) 1.17

Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor. J Mol Biol (2008) 1.14

Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res (2010) 1.12

Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am J Pathol (2005) 1.07

Clinical and radiological long-term results after operative treatment of chondroblastoma. Arch Orthop Trauma Surg (2010) 1.02

The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J (2004) 1.01

Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res (2005) 1.00

Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy. J Gen Virol (2008) 1.00

Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs (2006) 0.95

The systemic angiogenic response during bone healing. Arch Orthop Trauma Surg (2008) 0.94

LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancer. Infect Disord Drug Targets (2009) 0.94

Loosening after acetabular revision: comparison of trabecular metal and reinforcement rings. A systematic review. J Arthroplasty (2013) 0.92

Effect of platelet-rich plasma on the in vitro proliferation and osteogenic differentiation of human mesenchymal stem cells on distinct calcium phosphate scaffolds: the specific surface area makes a difference. J Biomater Appl (2008) 0.92

Therapeutic approaches for prion disorders. Expert Rev Anti Infect Ther (2007) 0.90

Clinical application of BMP 7 in long bone non-unions. Arch Orthop Trauma Surg (2009) 0.89

Progress in the palladium-catalyzed cyanation of aryl chlorides. Chemistry (2003) 0.88

Minimum ten-year results of a 28-mm metal-on-metal bearing in cementless total hip arthroplasty in patients fifty years of age and younger. Int Orthop (2013) 0.87

Polar pollutants entry into the water cycle by municipal wastewater: a European perspective. Environ Sci Technol (2006) 0.87

Inhibition of osteoclast generation: a novel function of the bone morphogenetic protein 7/osteogenic protein 1. Mediators Inflamm (2012) 0.86

10-year results of the uncemented Allofit press-fit cup in young patients. Acta Orthop (2014) 0.86

Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol (2006) 0.85

Reaming in treatment of non-unions in long bones: cytokine expression course as a tool for evaluation of non-union therapy. Arch Orthop Trauma Surg (2015) 0.85

A trans-dominant negative 37kDa/67kDa laminin receptor mutant impairs PrP(Sc) propagation in scrapie-infected neuronal cells. J Mol Biol (2006) 0.85

Functional and biophysical analyses of the class XIV Toxoplasma gondii myosin D. J Muscle Res Cell Motil (2006) 0.85

Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases. Mol Immunol (2007) 0.84

Subcellular localization of prion proteins and the 37 kDa/67 kDa laminin receptor fused to fluorescent proteins. Biochim Biophys Acta (2008) 0.84

Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks. Mod Pathol (2009) 0.83

Scrapie-infected transgenic mice expressing a laminin receptor decoy mutant reveal a prolonged incubation time associated with low levels of PrPres. J Mol Biol (2009) 0.83

Data visualization in environmental proteomics. Proteomics (2013) 0.82

Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment. Water Res (2007) 0.82

Failed surgical reconstruction of patellar tendon aplasia. A report of two cases. J Bone Joint Surg Am (2005) 0.81

Different isoforms of the non-integrin laminin receptor are present in mouse brain and bind PrP. Biol Chem (2003) 0.80

Cellular prion protein/laminin receptor: distribution in adult central nervous system and characterization of an isoform associated with a subtype of cortical neurons. Eur J Neurosci (2004) 0.80

Anti-LRP/LR antibody W3 hampers peripheral PrPSc propagation in scrapie infected mice. Prion (2007) 0.80

Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial. Am J Prev Med (2011) 0.79

Therapeutic approaches targeting the prion receptor LRP/LR. Vet Microbiol (2007) 0.79

Knock-down of the 37-kDa/67-kDa laminin receptor in mouse brain by transgenic expression of specific antisense LRP RNA. Transgenic Res (2004) 0.79

The influence of cementing technique in hip resurfacing arthroplasty on the initial stability of the femoral component. Int Orthop (2011) 0.79

Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis. J Heart Valve Dis (2006) 0.79

Pollution gets personal! A first population-based human biomonitoring study in Austria. Int J Hyg Environ Health (2011) 0.78

The prion-like protein Doppel fails to interact with itself, the prion protein and the 37 kDa/67 kDa laminin receptor in the yeast two-hybrid system. Biochim Biophys Acta (2004) 0.78

Quantitative determination of free intracellular alpha-keto acids in neutrophils. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.77

High-level expression and characterization of a glycosylated covalently linked dimer of the prion protein. Protein Eng (2002) 0.77

Upregulation in rat spinal cord microglia of the nonintegrin laminin receptor 37 kDa-LRP following activation by a traumatic lesion or peripheral injury. J Neurotrauma (2009) 0.77

Systemic response of the GH/IGF-I axis in timely versus delayed fracture healing. Growth Horm IGF Res (2007) 0.77

Intra- and interspecies interactions between prion proteins and effects of mutations and polymorphisms. Biol Chem (2003) 0.77

N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time. J Med Chem (2015) 0.77

Cigarette smoking influences the clinical and occupational outcome of patients with tibial shaft fractures. Injury (2012) 0.76

Time course of 25(OH)D3 vitamin D3 as well as PTH (parathyroid hormone) during fracture healing of patients with normal and low bone mineral density (BMD). BMC Musculoskelet Disord (2013) 0.75

Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis. Circ Cardiovasc Genet (2016) 0.75

Woodsmoke marker levoglucosan: kinetics in a self-experiment. Int J Occup Med Environ Health (2012) 0.75

New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals. Circ Cardiovasc Genet (2017) 0.75

Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet (2017) 0.75

Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance. J Cell Sci (2002) 0.75

[Therapeutic approaches for treatment of Creutzfeldt-Jakob disease]. Med Monatsschr Pharm (2008) 0.75

Modular chemosensors from self-assembled vesicle membranes with amphiphilic binding sites and reporter dyes. Angew Chem Int Ed Engl (2010) 0.75

Visualizing different uranium oxidation states during the surface alteration of uraninite and uranium tetrachloride. Naturwissenschaften (2009) 0.75

Recurrent episodes of stroke in a young adult: question. J Clin Neurosci (2016) 0.75

Correction to Nitrate Reverses Severe Nitrite Inhibition of Anaerobic Ammonium Oxidation (Anammox) Activity in Continuously-Fed Bioreactors. Environ Sci Technol (2016) 0.75

Electrochemical treatment of pharmaceutical wastewater by combining anodic oxidation with ozonation. J Environ Sci Health A Tox Hazard Subst Environ Eng (2008) 0.75

Effects of propofol and taurine on intracellular free amino acid profiles and immune function markers in neutrophils in vitro. Clin Chem Lab Med (2002) 0.75